10-Q Filing

AGILON HEALTH, INC. CIK: 1831097 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001564590-21-030059`
Period End Date	20210331
Filing Date	20210526
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	agl-10q_20210331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 40 Cash Flow Statement 55 Stockholders Equity 27

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$105.29M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$14.20M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$28.38M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$144.56M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$288.83M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$9.64M	USD	Point-in-time
Redeemable common stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Redeemable common stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$9.31M	USD	Point-in-time
Redeemable common stock, shares issued	`TemporaryEquitySharesIssued`	76.20M	shares	Point-in-time
Redeemable common stock, shares issued	`TemporaryEquitySharesIssued`	76.20M	shares	Point-in-time
Current assets held for sale and discontinued operations, net	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$4.83M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$417.63M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$294.20M	USD	Point-in-time
Redeemable common stock, outstanding	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Redeemable common stock, outstanding	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.46M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.80M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$60.47M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$61.61M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	249.37M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	249.47M	shares	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$43.70M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	249.47M	shares	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$47.26M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Non-current assets held for sale, net	`DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent`	$1.20M	USD	Point-in-time
Assets	`Assets`	$446.36M	USD	Point-in-time
Assets	`Assets`	$574.04M	USD	Point-in-time
Total assets	`Assets`	$446.36M	USD	Point-in-time
Liabilities	`Liabilities`	$421.59M	USD	Point-in-time
Total assets	`Assets`	$574.04M	USD	Point-in-time
Liabilities	`Liabilities`	$562.78M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$162.87M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$276.98M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$97.24M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$95.12M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.04M	USD	Point-in-time
Current liabilities held for sale and discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$3.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$266.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$372.11M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$99.41M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$64.67M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$91.26M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$90.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$421.59M	USD	Point-in-time
Total liabilities	`Liabilities`	$562.78M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingently redeemable common stock, $0.01 par value: 76,201 shares issued and outstanding	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Contingently redeemable common stock, $0.01 par value: 76,201 shares issued and outstanding	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Common stock, $0.01 par value: 500,000 shares authorized; 249,474 and 249,374 shares issued and outstanding, respectively	`CommonStockValue`	$2.49M	USD	Point-in-time
Common stock, $0.01 par value: 500,000 shares authorized; 249,474 and 249,374 shares issued and outstanding, respectively	`CommonStockValue`	$2.49M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$263.97M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$265.60M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-566.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-551.19M	USD	Point-in-time
Total agilon health, inc. stockholders' equity	`StockholdersEquity`	$-284.73M	USD	Point-in-time
Total agilon health, inc. stockholders' equity	`StockholdersEquity`	$-298.17M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-73.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-247.51M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Total liabilities, contingently redeemable common stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$574.04M	USD	Point-in-time
Total liabilities, contingently redeemable common stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$446.36M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$291.05M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$413.10M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$247.65M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$360.35M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$23.66M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$18.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$27.61M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$37.78M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.43M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.20M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$425.22M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$296.88M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-5.83M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-12.12M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$122.00K	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$1.34M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.94M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.15M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.72M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.86M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$16.00K	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-7.86M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-13.74M	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-1.35M	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-8.09M	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$64.00K	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$149.00K	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.42M	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-8.24M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-15.15M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-16.10M	USD	1 Quarter
Noncontrolling interests share in earnings (loss)	`NetIncomeLossAttributableToNoncontrollingInterest`	$73.00K	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-15.08M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-16.10M	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.02	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.04	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.01	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.03	USD	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	321.25M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	325.66M	shares	1 Quarter

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-15.15M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-16.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.48M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.36M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.07M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.47M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.19M	USD	1 Quarter
Other noncash items	`OtherNoncashIncomeExpense`	$-837.00K	USD	1 Quarter
Other noncash items	`OtherNoncashIncomeExpense`	$-1.77M	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$15.30M	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$33.58M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-40.83M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.13M	USD	1 Quarter
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$178.00K	USD	1 Quarter
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$345.00K	USD	1 Quarter
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$33.00K	USD	1 Quarter
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$3.99M	USD	1 Quarter
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$359.00K	USD	1 Quarter
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$1.20M	USD	1 Quarter
Proceeds from repayment of loans receivable	`ProceedsFromCollectionOfLoansReceivable`	$1.06M	USD	1 Quarter
Proceeds from sale of business, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-3.71M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$319.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.07M	USD	1 Quarter
Proceeds from equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$28.13M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$165.00K	USD	1 Quarter
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$100.00M	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$1.22M	USD	1 Quarter
Repayments of long-term borrowings	`RepaymentsOfLongTermDebt`	$68.65M	USD	1 Quarter
Repayments of long-term borrowings	`RepaymentsOfLongTermDebt`	$760.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.37M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$30.30M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-19.60M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.56M	USD	1 Quarter
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$119.49M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$142.56M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$4.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$147.17M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$119.49M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$119.49M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$142.56M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$4.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$147.17M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$119.49M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-247.51M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Contingently Redeemable Common Stock, Beginning balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Beginning balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Beginning balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Contingently Redeemable Common Stock, Beginning balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	249.47M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$-15.15M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-16.10M	USD	1 Quarter
Issuance of contingently redeemable common stock	`IssuanceOfContingentlyRedeemableCommonStockValue`	$-460.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$165.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.07M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.47M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-247.51M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Contingently Redeemable Common Stock, Ending balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Ending balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Ending balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Contingently Redeemable Common Stock, Ending balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	249.47M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.